Projects

ACHIEVE -Aldosterone bloCkade for Health Improvement EValuation in End-stage renal disease

Project Description

Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.

Project Duration

2019 - 2025

Project Lead

Dr Denis Xavier

Authors

Dr Denis Xavier

Project Status

completed

Project Type

CIHR (Canadian Institutes of Health Research) through Population Health Research Institute (PHRI), McMaster University, Canada.